[go: up one dir, main page]

BRPI0519198A2 - moduladores de delta-opiàide tricÍclicos - Google Patents

moduladores de delta-opiàide tricÍclicos

Info

Publication number
BRPI0519198A2
BRPI0519198A2 BRPI0519198-0A BRPI0519198A BRPI0519198A2 BR PI0519198 A2 BRPI0519198 A2 BR PI0519198A2 BR PI0519198 A BRPI0519198 A BR PI0519198A BR PI0519198 A2 BRPI0519198 A2 BR PI0519198A2
Authority
BR
Brazil
Prior art keywords
opioid
tricyclic
modulators
delta
opioid modulators
Prior art date
Application number
BRPI0519198-0A
Other languages
English (en)
Inventor
John R Carson
Scott L Dax
Bart Decorte
Li Liu
James J Mcnally
Mark Mcdonnell
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0519198A2 publication Critical patent/BRPI0519198A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

MODULADORES DE DELTA-OPIàIDE TRICÍCLICOS. A invenção refere-se a moduladores de receptor deita opiálde da fórmula (1). Mais especificamente, a invenção refere-se a moduladores <sym>-opióide triçíclicos. Composições farmacêuticas e veterinárias para tratar dor branda a severa e várias doenças que são também descritas.
BRPI0519198-0A 2004-12-22 2005-12-21 moduladores de delta-opiàide tricÍclicos BRPI0519198A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63831404P 2004-12-22 2004-12-22
PCT/US2005/046690 WO2006069275A1 (en) 2004-12-22 2005-12-21 Tricyclic delta-opioid modulators

Publications (1)

Publication Number Publication Date
BRPI0519198A2 true BRPI0519198A2 (pt) 2008-12-30

Family

ID=36177990

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519198-0A BRPI0519198A2 (pt) 2004-12-22 2005-12-21 moduladores de delta-opiàide tricÍclicos

Country Status (10)

Country Link
US (2) US20060135522A1 (pt)
EP (1) EP1836196A1 (pt)
JP (1) JP2008525481A (pt)
KR (1) KR20070092286A (pt)
CN (1) CN101128458A (pt)
AU (1) AU2005319059A1 (pt)
BR (1) BRPI0519198A2 (pt)
CA (1) CA2592462A1 (pt)
MX (1) MX2007007625A (pt)
WO (1) WO2006069275A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644373A1 (en) 2003-06-27 2006-04-12 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
CN101039940A (zh) * 2004-08-05 2007-09-19 詹森药业有限公司 三环δ－阿片样物质调节剂
EP1836196A1 (en) * 2004-12-22 2007-09-26 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
JP2008525482A (ja) 2004-12-22 2008-07-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式ｏ−オピオイド調節剤
MX2007007627A (es) * 2004-12-22 2008-01-28 Johnson & Johnson Moduladores delta-opioides triciclicos.
BRPI0606402A2 (pt) * 2005-01-06 2009-06-23 Janssen Pharmaceutica Nv moduladores de delta-opióide tricìclico
AU2006259273A1 (en) * 2005-06-16 2006-12-28 Janssen Pharmaceutica N.V. Tricyclic opioid modulators
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
KR101275092B1 (ko) * 2011-05-19 2013-06-17 한미정밀화학주식회사 아질사르탄의 개선된 제조방법
CN102680310A (zh) * 2012-03-20 2012-09-19 中国人民解放军第二军医大学 一种微波辅助血浆样品前处理方法及在血浆代谢组学分析中的应用
EP3248230B1 (de) * 2015-01-20 2020-05-06 cynora GmbH Verwendung organischer moleküle in optoelektronischen bauelementen
CN108069935A (zh) * 2017-12-25 2018-05-25 天津瑞岭化工有限公司 一种2,4-二乙基硫杂蒽酮的制备方法
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法
CN115521319A (zh) * 2021-06-25 2022-12-27 沈阳兴齐眼药股份有限公司 2-(10-氧代-9-氧杂-1-氮杂蒽-6-基)丙酸酯类化合物的制备方法及用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2386006A (en) * 1943-09-09 1945-10-02 New York Air Brake Co Sander
US2368006A (en) * 1943-10-07 1945-01-23 Searle & Co Heterocyclic tertiary amines
US2784185A (en) * 1953-03-27 1957-03-05 Promonta Chem Fab Phenothiazine compounds
US2901478A (en) * 1957-02-11 1959-08-25 Promonta Chem Fab Phenothiazine compounds
US3179665A (en) * 1959-12-16 1965-04-20 Wander Ag Dr A 9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes
DE1159954B (de) * 1961-11-25 1963-12-27 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
NL6818027A (pt) * 1968-01-09 1969-07-11
US3987042A (en) * 1969-03-03 1976-10-19 Claude Gueremy Phenothiazine derivative
US3931232A (en) * 1974-06-24 1976-01-06 Smithkline Corporation 3-Alkyl xanthene compounds
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
ZA756550B (en) * 1974-11-06 1976-09-29 Smithkline Corp Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4285956A (en) * 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4666907A (en) * 1983-10-05 1987-05-19 Merck Frosst Canada, Inc. Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
FR2689013B1 (fr) * 1992-03-30 1995-05-05 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique des dérivés de la phénothiazine.
ZA978792B (en) * 1996-10-04 1998-04-06 Novo Nordisk As N-substituted azaheterocyclic compounds.
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
US6040318A (en) * 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
AU2002234010A1 (en) * 2000-12-14 2002-06-24 Ortho-Mcneil Pharmaceutical, Inc. Benzamidine derivatives
US6601009B2 (en) * 2001-07-12 2003-07-29 Yahoo Inc Method and system of automatic bandwidth detection
US7060711B2 (en) * 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
US20040082612A1 (en) * 2002-10-15 2004-04-29 Baxter Ellen W Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
EP1644373A1 (en) * 2003-06-27 2006-04-12 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
CN101039940A (zh) * 2004-08-05 2007-09-19 詹森药业有限公司 三环δ－阿片样物质调节剂
JP2008525482A (ja) * 2004-12-22 2008-07-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式ｏ−オピオイド調節剤
EP1836196A1 (en) * 2004-12-22 2007-09-26 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
MX2007007627A (es) * 2004-12-22 2008-01-28 Johnson & Johnson Moduladores delta-opioides triciclicos.
BRPI0606402A2 (pt) * 2005-01-06 2009-06-23 Janssen Pharmaceutica Nv moduladores de delta-opióide tricìclico
AU2006259273A1 (en) * 2005-06-16 2006-12-28 Janssen Pharmaceutica N.V. Tricyclic opioid modulators

Also Published As

Publication number Publication date
MX2007007625A (es) 2008-01-28
US20080306111A1 (en) 2008-12-11
US20060135522A1 (en) 2006-06-22
KR20070092286A (ko) 2007-09-12
EP1836196A1 (en) 2007-09-26
JP2008525481A (ja) 2008-07-17
CN101128458A (zh) 2008-02-20
WO2006069275A1 (en) 2006-06-29
AU2005319059A1 (en) 2006-06-29
CA2592462A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
BRPI0410711A (pt) novos compostos
BRPI0411998A (pt) moduladores delta-opióides tricìclicos
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
PA8493701A1 (es) Compuestos para tratar la obesidad
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
GEP20074197B (en) 5ht2c receptor modulators
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
SE0302232D0 (sv) Novel Compounds
NO20045589L (no) Nye forbindelser
EA200601798A1 (ru) Замещенные соединения морфолина для лечения расстройств центральной нервной системы
NO20073776L (no) Trisykliske delta-opioidmodulatorer
UY28482A1 (es) Nuevos compuestos
CY1111977T1 (el) Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
BRPI0519198A2 (pt) moduladores de delta-opiàide tricÍclicos
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
TW200716134A (en) Tricyclic opioid modulators
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
CY1113759T1 (el) Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
EA200801302A1 (ru) Композиции и способы лечения нарушений цнс
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
BRPI0513075A (pt) moduladores gama-opióides tricìclicos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.